NY-NITROGEN A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.2% 3.6% 2.6% 4.3% 2.0%  
Credit score (0-100)  65 51 61 46 69  
Credit rating  BBB BBB BBB BBB A  
Credit limit (kDKK)  1.6 0.0 0.1 0.0 7.8  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  -373 -8,252 -1,770 -6,520 46.6  
EBITDA  -790 -8,516 -870 -320 -353  
EBIT  -790 -8,516 -1,770 -6,520 46.6  
Pre-tax profit (PTP)  -812.9 -8,532.5 -1,777.0 -6,509.4 68.9  
Net earnings  -634.6 -6,655.3 -1,386.1 -5,077.0 53.5  
Pre-tax profit without non-rec. items  -813 -8,532 -1,777 -6,509 68.9  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  66,027 58,600 57,700 51,500 51,900  
Shareholders equity total  60,778 54,123 52,737 47,660 47,713  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  69,060 60,471 59,020 52,573 52,723  

Net Debt  -2,840 -1,789 -725 -992 -734  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -373 -8,252 -1,770 -6,520 46.6  
Gross profit growth  0.0% -2,110.2% 78.5% -268.3% 0.0%  
Employees  1 1 0 0 0  
Employee growth %  0.0% 0.0% -100.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  69,060 60,471 59,020 52,573 52,723  
Balance sheet change%  -0.9% -12.4% -2.4% -10.9% 0.3%  
Added value  -790.0 -8,515.9 -1,770.2 -6,520.3 46.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 -7,427 -900 -6,200 400  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 -3.0 -4.0 -5.0 1.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  211.6% 103.2% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -1.1% -13.1% -3.0% -11.7% 0.1%  
ROI %  -1.1% -13.2% -3.1% -13.0% 0.1%  
ROE %  -1.0% -11.6% -2.6% -10.1% 0.1%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  88.0% 89.5% 89.4% 90.7% 90.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  359.5% 21.0% 83.3% 309.8% 207.6%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  13.8 11.5 25.4 22.6 15.6  
Current Ratio  13.8 11.5 25.4 22.6 15.6  
Cash and cash equivalent  2,840.1 1,789.0 724.6 992.2 733.5  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  97.0 63.1 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  2,813.0 1,707.5 1,268.6 1,025.5 770.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -790 -8,516 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -790 -8,516 0 0 0  
EBIT / employee  -790 -8,516 0 0 0  
Net earnings / employee  -635 -6,655 0 0 0